Valeo Pharma Ownership
| VPHIF Stock | USD 0.05 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Valeo |
Valeo Pink Sheet Ownership Analysis
About 48.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.22. Valeo Pharma had not issued any dividends in recent years. Valeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceutical products with primary focus on respiratory, speciality, and hospital generic products in Canada. The company was incorporated in 2003 and is headquartered in Kirkland, Canada. Valeo Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 100 people.The quote for Valeo Pharma is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call Steven CA at 514 694 0150 or visit https://www.valeopharma.com.Currently Active Assets on Macroaxis
Other Information on Investing in Valeo Pink Sheet
Valeo Pharma financial ratios help investors to determine whether Valeo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valeo with respect to the benefits of owning Valeo Pharma security.